Throat Carcinoma — Trials

Throat Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,035 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 369
Recruiting: 201
Ph III recruiting: 58
Growth YoY: +7.8%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 31.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (87)

clinicaltrialsPublishedShowing 651–700 of 1,035 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05448885	Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma	unknown	Phase 2	50	Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER	1	Jul 8, 2022	clinicaltrials
NCT04398056	Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma	unknown	Phase 2	22	Sun Yat-sen UniversityOTHER	1	Jul 6, 2022	clinicaltrials